Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 07, 2022

SELL
$155.97 - $200.09 $259,066 - $332,349
-1,661 Reduced 33.32%
3,324 $571,000
Q1 2022

Apr 11, 2022

BUY
$181.39 - $234.03 $15,418 - $19,892
85 Added 1.73%
4,985 $940,000
Q4 2020

Jan 12, 2021

BUY
$157.07 - $174.35 $15,707 - $17,435
100 Added 2.08%
4,900 $811,000
Q1 2020

Apr 23, 2020

SELL
$92.66 - $144.94 $6,578 - $10,290
-71 Reduced 1.46%
4,800 $565,000
Q4 2019

Jan 14, 2020

BUY
$116.25 - $133.25 $11,625 - $13,325
100 Added 2.1%
4,871 $645,000
Q3 2019

Oct 10, 2019

SELL
$112.57 - $128.43 $2,814 - $3,210
-25 Reduced 0.52%
4,771 $594,000
Q2 2019

Jul 18, 2019

BUY
$97.98 - $114.28 $469,912 - $548,086
4,796 New
4,796 $544,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Legacy Private Trust Co. Portfolio

Follow Legacy Private Trust Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Private Trust Co., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Private Trust Co. with notifications on news.